Medical trials centres to be launched in investment worth more than £10m
Two clinical trial centres funded by more than £10m worth of “public-private investment” are to open in Yorkshire.
Bradford Teaching Hospitals NHS Foundation Trust will be awarded £6.9m, and £3.3m will be given to Sheffield Children’s NHS Foundation Trust.
Across the UK, a total of 20 commercial research delivery centres (CRDCs) will receive £100m from pharmaceutical companies and the National Institute for Health and Care Research.
The Government has said this investment will boost the economy, fast-track new medicines and allow more people to benefit from medical trials.
The centre at Sheffield Children’s Hospital will concentrate on preventing or altering the course of diseases in babies.
Its director, professor Michael Cork, explained access to treatments at the trial stage could “change the lives of children and young people”.
The centres will also mean the staging of trials could be expanded to under-served areas, enabling more people to take part.
Professor Dinesh Saralaya, director of the Bradford CRDC, added it would “improve healthcare outcomes of our diverse population”.
Research across the UK will be carried out into conditions including cancer and obesity, as well as infectious diseases such as flu and respiratory syncytial virus (RSV). CRDCs are to be launched in England, Wales, Scotland and Northern Ireland.
The Department of Health and Social Care says the “vast majority” of companies which sell branded medicines to the NHS are contributing to the investment.
More articles in
Sectors
